XML 31 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 2 - Acquisitions and Dispositions (Details) (USD $)
 12 Months Ended 0 Months Ended 0 Months Ended 12 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2012
May 15, 2012
Scenario, Previously Reported [Member]
Bios International Corporation [Member]
Aug. 12, 2013
Nusonics Product Line Business [Member]
Nov. 06, 2013
Amega Scientific Corporation [Member]
May 15, 2012
Amega Scientific Corporation [Member]
Nov. 06, 2013
TempSys Inc [Member]
May 15, 2012
Bios International Corporation [Member]
Mar. 31, 2014
Bios International Corporation [Member]
Nov. 06, 2013
Minimum [Member]
Amega Scientific Corporation [Member]
Nov. 06, 2013
Maximum [Member]
Amega Scientific Corporation [Member]
Note 2 - Acquisitions and Dispositions (Details) [Line Items]                        
Payments to Acquire Businesses, Net of Cash Acquired $ 22,758,000 $ 16,660,000 $ 737,000 [1]                  
Business Acquisition Agreement Holdback Payment Period from Effective Date Less Any Losses Incurred by Buyer Payable to Seller           3 years            
Business Acquisition Earn Out Period for Determination of Contingent Consideration           3 years     3 years      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low           0 0   0      
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High           10,000,000 10,000,000   6,710,000      
Business Acquisition Revenue Required in Three Years Subsequent to Acquisition for Payment of Contingent Consideration                     31,625,000 43,500,000
Business Combination, Contingent Consideration, Liability 1,620,000 2,140,000   2,140,000   500,000     2,140,000 1,120,000    
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net           12,768,000   9,826,000 18,800,000      
Business Acquisition Minimum Revenue Required in Three Years Subsequent to Acquisition for Payment of Contingent Consideration                 22,127,000      
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (1,020,000)                 (1,020,000)    
Proceeds from Divestiture of Businesses 661,000       661,000              
Disposal Group Not Discontinued Operation Carrying Value         193,000              
Gain (Loss) on Disposition of Business $ 420,000       $ 468,000              
[1] In December 2011, we settled the $600 holdback amount from our acquisition of the assets of Apex Laboratories, Inc. by paying $562 and returning $38 of accounts receivable.